(Q43275143)

18 November 2017

title

Class IV-G and IV-S lupus nephritis in Chinese patients: a large cohort study from a single center (English)

1 reference

18 November 2017

1 reference

F Yu

1

1 reference

18 November 2017

Y Tan

2

1 reference

18 November 2017

L-H Wu

3

1 reference

18 November 2017

S-N Zhu

4

1 reference

18 November 2017

G Liu

5

1 reference

18 November 2017

M-H Zhao

6

1 reference

18 November 2017

publication date

1 October 2009

1 reference

18 November 2017

1 reference

18 November 2017

volume

18

1 reference

18 November 2017

issue

12

1 reference

18 November 2017

page(s)

1073-1081

1 reference

New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences?

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

The prognosis of segmental glomerulonephritis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

The classification of glomerulonephritis in systemic lupus erythematosus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106795

21 January 2018

Identifiers

DOI

10.1177/0961203309106795

1 reference

release_dmjfks2rirdlti2rnhw4feuiue

18 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dmjfks2rirdlti2rnhw4feuiue

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference